Catalog No.
Product Name
Application
Product Information
Citations
-
Antibiotic
Ramoplanin is a broad-spectrum lipoglycodepsipeptide antibiotic that targets gram-positive bacteria. Derived from Actinoplanes species, it exhibits potent antimicrobial activity, making it effective against various resistant strains. This compound is significant for research applications focusing on antibiotic resistance mechanisms and the development of novel antimicrobial therapies. -
Antibiotic
Hygromycin A is a spirochete-specific antibiotic targeting Borrelia burgdorferi, the causative agent of Lyme disease. It exhibits potent antibacterial activity against spirochetes, making it a valuable tool for research into Lyme disease and gut health. Hygromycin A is suitable for studies investigating spirochete pathogenesis and potential therapeutic interventions. -
Antibiotic
Cefetamet is a cephalosporin antibiotic that functions by binding to bacterial penicillin-binding proteins (PBPs), with an IC50 of 2.5 μg/mL for PBP3 in Escherichia coli W3110. It exhibits significant antibacterial activity against a variety of Gram-negative bacteria, including Enterobacteriaceae, Neisseria species, and Haemophilus influenzae, as well as Gram-positive bacteria such as Streptococcus. Additionally, Cefetamet demonstrates bactericidal effects against Treponema pallidum. This compound is valuable for researching respiratory, urinary, and ear, nose, and throat infections, in addition to syphilis. -
Antibiotic Agent
Oxytetracycline hydrochloride is an antibiotic from the tetracycline class, primarily targeting bacterial protein synthesis. It effectively inhibits both Gram-negative and Gram-positive bacteria by preventing the binding of aminoacyl-tRNA to the mRNA-ribosomal RNA complex. Additionally, oxytetracycline hydrochloride exhibits anti-HSV-1 activity, making it valuable for research applications in microbiology and virology. -
Polypeptide Antibiotic
Colistin is a polypeptide antibiotic primarily targeting Gram-negative bacteria. It demonstrates potent activity against multidrug-resistant strains such as Pseudomonas aeruginosa, Acinetobacter baumannii, and Klebsiella pneumoniae. Due to its nephrotoxic potential, careful consideration is required during research. Colistin is valuable for studying infections caused by Gram-negative bacilli and exploring antibiotic resistance mechanisms. -
β-lactamase Inhibitor
Clavulanate potassium is a potent β-lactamase inhibitor that enhances the effectiveness of β-lactam antibiotics by inhibiting bacterial enzyme activity. It is primarily used in research to study antimicrobial resistance mechanisms and to evaluate the synergy of antibiotic combinations. Clavulanate potassium is essential in elucidating bacterial adaptations and informing therapeutic strategies against resistant organisms. -
Antibiotic
Penicillin V, also known as Phenoxymethylpenicillin, is a potent, orally bioavailable antibiotic targeting bacterial cell wall synthesis. It exhibits significant antibacterial activity against Streptococci, Clostridium difficile, and Staphylococcus aureus. This compound is valuable for research applications related to otitis, sinusitis, pharyngitis, and tonsillitis, providing insights into bacterial pathogenesis and resistance mechanisms. -
Antibiotic
Cefacetrile is a broad-spectrum antibiotic with activity against both gram-positive and gram-negative bacteria. It targets bacterial cell wall synthesis, inhibiting peptidoglycan cross-linking, which leads to cell lysis and death. This compound is primarily utilized in research involving bacterial infections and offers valuable insights into antibiotic mechanisms and resistance. -
Lipoglycopeptide Antibiotic
Dalbavancin is a semisynthetic lipoglycopeptide antibiotic targeting Gram-positive bacteria. It exhibits potent bactericidal activity, with minimal inhibitory concentrations (MIC90) of 0.06 μg/mL against Staphylococcus aureus and 0.25 μg/mL against Bacillus anthracis. This compound is primarily utilized in research applications focused on bacterial infections and the development of novel antimicrobial therapies. -
Antibiotic
Micronomicin is an aminoglycoside antibiotic that exerts its effects primarily by binding to bacterial ribosomal RNA, leading to disruption of protein synthesis. This compound exhibits significant antibacterial and bactericidal activity against a wide range of Gram-negative and some Gram-positive bacteria. Micronomicin is utilized in research applications related to antibiotic resistance, infection models, and the study of microbial pathogenesis. -
β-lactamase Inhibitor
Clavulanate lithium is a potent β-lactamase inhibitor that enhances the efficacy of β-lactam antibiotics by inhibiting bacterial enzymes responsible for antibiotic resistance. Its ability to combat antibiotic resistance makes it invaluable in research focused on understanding and overcoming treatment failures caused by resistant pathogens. Clavulanate lithium is commonly used in studies investigating the mechanisms of resistance and in the development of novel therapeutics. -
Antibiotic
Telavancin hydrochloride is an antibiotic that functions primarily by inhibiting cell wall synthesis and disrupting cell membrane barrier function. This semisynthetic derivative of vancomycin demonstrates significant antibacterial activity against antibiotic-resistant Staphylococcus aureus strains, including MRSA, VISA, and hVISA. Telavancin hydrochloride is particularly effective in treating complicated skin and skin structure infections (cSSSI) caused by gram-positive bacteria. This compound is valuable for research into antibiotic resistance and the development of novel antimicrobial therapies. -
Antibacterial Agent
Thiocarlide is an effective antibacterial agent primarily targeting Mycobacterium species. It demonstrates significant inhibitory activity against Mycobacterium tuberculosis H37Rv, Mycobacterium bovis BCG, Mycobacterium avium, and Mycobacterium aurum A+, with minimum inhibitory concentrations (MICs) of 2.5, 0.5, 2.0, and 2.0 μg/mL, respectively. Thiocarlide can be utilized in research applications focused on tuberculosis and other mycobacterial infections. -
Lincosamide Antibiotic
Lincomycin is a lincosamide antibiotic that targets bacterial protein synthesis by inhibiting the 50S ribosomal subunit. It exhibits potent antimicrobial activity against a range of Gram-positive bacteria, making it invaluable in studying bacterial infections and resistance mechanisms. Lincomycin is commonly used in research applications focusing on microbial pathogenesis and the development of antibiotic resistance. -
Antibiotic
Djalonensone is an antibiotic compound isolated from the roots of Anthocleista djalonensis (Loganiaceae). It exhibits significant antimicrobial activity, making it a valuable tool in research focused on developing new antibiotic therapies. Its unique properties also serve as an important taxonomic marker for the identification and classification of this plant species. -
Antibiotic
Bleomycin B4 is an antibiotic that exhibits potent antitumor activity. It functions by inducing DNA strand breaks, leading to cell cycle arrest and apoptosis in cancer cells. This compound is commonly utilized in cancer research to explore therapeutic strategies and mechanisms of action in oncology. -
Antibacterial Agent
Cyclacillin is an orally active aminopenicillin antibiotic that primarily targets bacterial cell wall synthesis. It exhibits significant antibacterial activity against a broad spectrum of gram-positive and gram-negative pathogens. This compound is useful in research applications focused on infection models and the study of antibiotic resistance mechanisms. -
Antibiotic
Enduracidin is a polypeptide antibiotic that exerts its antibacterial effects by inhibiting cell wall synthesis in susceptible bacteria. Originally derived from Streptomyces fungicides, this compound is effective against a range of Gram-positive organisms. Enduracidin is primarily utilized in research applications focused on antibiotic resistance and the development of novel antibacterial agents. -
Antibacterial Agent
Tellimagrandin II is an antibacterial agent that disrupts the integrity of the cell wall in Staphylococcus aureus, leading to cell lysis and loss of cytoplasmic contents. Additionally, it demonstrates anti-inflammatory properties and inhibits acetylcholinesterase (AChE), which may contribute to improvements in memory impairment. This compound is of interest in research focusing on antibacterial strategies, inflammatory pathways, and neurodegenerative conditions. -
Antibiotic
Kasugamycin is an antibiotic that targets the ribosomal subunits by binding to both the 30S and 70S ribosomes, without interacting with isolated 50S subunits. It mimics mRNA nucleotides, leading to destabilization of tRNA binding and inhibition of canonical translation initiation. This compound is valuable for research in antibiotic mechanisms, ribosomal function, and the study of bacterial protein synthesis. -
Antibiotic
Thiolactomycin is an antibiotic that targets the FabB enzyme, effectively inhibiting the synthesis of fatty acids and mycolic acids. This compound demonstrates potent activity against Gram-negative anaerobes and exhibits inhibitory effects on malaria parasites and trypanosomes. It is a valuable reagent for researchers investigating antibiotic mechanisms and fatty acid biosynthesis pathways, as well as for studies focused on protozoan infections. -
Polypeptide Antibiotics
Polymyxin B2 is a polypeptide antibiotic that primarily targets the cell membrane of gram-negative bacteria. It exerts its antibacterial effect by binding to lipopolysaccharide components, leading to membrane disruption and subsequent cell lysis. This compound is relevant for antibiotic research and development, particularly in addressing drug-resistant bacterial strains. -
Macrolide Antibiotic
Venturicidin A is a macrolide antibiotic that acts as a potent inhibitor of ATP synthase. Derived from actinomycetes, it enhances the efficacy of the aminoglycoside antibiotic gentamicin against multidrug-resistant strains of Staphylococcus, Enterococcus, and Pseudomonas aeruginosa. Although Venturicidin A demonstrates significant antibacterial activity, it also exhibits notable toxicity towards human embryonic kidney (HEK) cells, with an IC50 value of 31 μg/mL, making it a valuable compound for research in antibiotic resistance and cellular response assessments. -
Antibiotic
Benzylideneacetone operates as an orally active antibiotic with a primary mechanism of inhibiting tyrosinase and phospholipase A2. It demonstrates antibacterial activity against select gram-negative plant-pathogenic bacteria, making it a valuable compound for agricultural research. Additionally, Benzylideneacetone serves as a versatile starting material in the synthesis of chemicals and pharmaceuticals, and it is utilized as a flavoring additive in certain food applications. -
Bacterial Inhibitor
Flomoxef sodium is an oxacephem antibiotic that primarily targets bacterial ribosomes, inhibiting protein synthesis. It exhibits potent activity against a range of Gram-positive bacteria, making it suitable for research in antimicrobial resistance and bacterial infections. Flomoxef sodium can be utilized in studies exploring antibiotic efficacy and drug resistance mechanisms. -
Quinolone Antibiotic
Nemonoxacin malate is a nonfluorinated quinolone antibiotic that targets bacterial DNA gyrase and topoisomerase IV. This compound demonstrates broad-spectrum antimicrobial activity against Gram-positive, Gram-negative, and atypical pathogens, including drug-resistant Streptococcus pneumoniae and Methicillin-resistant Staphylococcus aureus. Nemonoxacin malate is valuable for research focused on community-acquired pneumonia and other infections where antibiotic resistance is a concern. -
Bacterial Inhibitor
Virginiamycin S1 is a cyclic hexadepsipeptide antibiotic that inhibits bacterial protein synthesis by targeting aminoacyl-tRNA binding and peptide bond formation. As a type B compound in the streptogramin family, it exhibits potent bactericidal activity against a diverse array of Gram-positive bacteria. Virginiamycin S1, particularly in combination with virginiamycin M1, is valuable in research focused on overcoming multidrug-resistant bacterial infections. Its application is relevant in fields such as microbiology and pharmacology, particularly in the study of antibiotic efficacy and resistance mechanisms. -
Antibacterial Agent
Rosoxacin is an orally active broad-spectrum antibacterial quinolone antibiotic that primarily targets Gram-negative bacteria. It demonstrates effective inhibition against Neisseria gonorrhoeae, with a minimum inhibitory concentration (MIC) range of 0.03-0.125 µg/mL. This compound is valuable in research related to urinary tract infections and various sexually transmitted diseases, providing insights into bacterial resistance and treatment efficacy. -
Linker-Antibiotic Intermediate
MC-VC-PAB-O-Gemcitabine is a linker-antibiotic intermediate specifically designed for use in antibody-antibiotic conjugate (AAC) applications. This compound features a conjugation with the antibiotic Gemcitabine, facilitating targeted delivery and enhancing the therapeutic potential against bacterial infections. Its utility in research encompasses the exploration of immunotherapy strategies and the development of novel antibacterial agents. -
Cephalosporin Antibiotic
Ceftolozane TFA is a cephalosporin antibiotic that targets Gram-negative bacteria by disrupting cell wall synthesis. Its potent antibacterial activity makes it a valuable tool in combating resistant infections. Ceftolozane TFA can be utilized in research aimed at developing novel antibiotics with improved efficacy and safety profiles. -
Antibiotic Peptide
Aurein 1.2 is an antibiotic peptide derived from amphibian sources, exhibiting potent antimicrobial and anticancer properties. This peptide targets bacterial membranes, leading to disruption and cell death, making it valuable in the study of antibiotic resistance and cancer therapeutics. Aurein 1.2 is ideal for research applications focused on the development of novel antimicrobial agents and exploring mechanisms of cancer cell apoptosis. -
Aminoglycoside Antibiotic
Neamine is an aminoglycoside antibiotic and a degradation product of Neomycin, known for its broad-spectrum antibacterial properties. It exerts anti-angiogenic effects by targeting angiogenin, making it valuable in cancer research. Additionally, Neamine demonstrates neuroprotective and antitumor activities, supporting its potential in diverse biological studies. -
β-Lactam Antibiotic
Cephalothin is a semi-synthetic cephalosporin antibiotic classified as a β-lactam antibiotic. It exerts its antibacterial activity by inhibiting class C β-lactamase AmpC with a Ki of 0.32 µM while also binding to penicillin-binding proteins, thereby disrupting the cross-linking of peptidoglycan in the bacterial cell wall. This mechanism impedes bacterial cell wall synthesis, allowing it to effectively target a broad spectrum of bacteria. Cephalothin is applicable in studies related to hematology and nephrotoxicity. -
Antibacterial Agent
Targocil-II is an ABC transporter inhibitor demonstrating an IC50 value of 137 nM. By binding to allosteric sites within the transmembrane domain, Targocil-II effectively prevents ATP hydrolysis. This compound exhibits antibacterial activity, making it a valuable tool for research focused on combating multidrug resistance in bacterial pathogens. -
Antibacterial Agent
CRS3123 dihydrochloride is a synthetic antibacterial agent that effectively targets methionyl-tRNA synthetase (MetRS) in Clostridioides difficile. By inhibiting MetRS, CRS3123 dihydrochloride reduces toxin production and spore formation associated with Clostridioides difficile infections (CDI). This compound serves as a valuable tool for research into CDI and potential therapeutic strategies. -
Cephem Antibiotic
Cefcapene pivoxil hydrochloride is a pivalate ester prodrug of Cefcapene, functioning as a third-generation cephalosporin antibiotic. It demonstrates a broad spectrum of antibacterial activity, making it valuable in various microbiological studies. Additionally, this compound may hold potential for research applications related to palmoplantar pustulosis (PPP). -
Antitumor Antibiotic/AdoHcy hydrolase Inhibitor
Neplanocin A is an antitumor antibiotic that functions as an irreversible inhibitor of AdoHcy hydrolase, with a Ki of 8.39 nM. It exhibits significant antitumor activity against murine L1210 leukemia cells and also demonstrates antiviral properties, notably against the vaccinia virus. This compound is isolated from the marine-derived organism Ampulariella regularis, making it a valuable reagent for research in cancer therapeutics and virology. -
Antibiotic
Avrainvillamide is a naturally occurring alkaloid that functions as an antibiotic by targeting the nuclear chaperone nucleophosmin (NPM1), which is often overexpressed in various human tumors. This compound exhibits antiproliferative properties by directly binding to NPM1 and Crm1, and disrupting their interactions with native cellular partners. Avrainvillamide demonstrates strong antibacterial activity against multi-drug resistant strains of Staphylococcus aureus, Streptococcus pyogenes, and Enterococcus faecalis, with minimum inhibitory concentrations (MICs) of 12.5, 12.5, and 25 μg/ml, respectively. Its unique mechanism and efficacy make it a valuable tool in antibiotic research and cancer biology studies. -
Gentamicin-Type Antibiotic
Micronomicin sulfate is a gentamicin-type aminoglycoside antibiotic derived from Micromonospora. It exhibits broad-spectrum antibacterial activity, particularly effective against Pseudomonas, Proteus, Klebsiella pneumoniae, and Serratia, with MIC values ranging from 0.001 to 8.3 μg/ml. This compound is utilized in research focused on bacterial infections and antibiotic resistance mechanisms, making it a valuable tool in microbiological studies and drug development. -
Antibacterial Agent
Temafloxacin is an orally active quinolone antibiotic that exhibits broad-spectrum antibacterial activity. Primarily utilized for the treatment of lower respiratory and genitourinary tract infections, Temafloxacin demonstrates favorable tolerability in patients. Its efficacy in combating various bacterial pathogens makes it a valuable tool in microbiological research and infection control studies. -
Antibacterial Agent
Cefpiramide is a semisynthetic cephalosporin antibiotic targeting bacterial cell wall synthesis. It exhibits broad-spectrum antibacterial activity against both gram-positive and gram-negative bacteria, making it valuable for combating various bacterial infections. Cefpiramide is also moderately susceptible to β-lactamase, which is relevant in resistance studies and the evaluation of antibacterial efficacy. This reagent is suited for research applications in microbiology and antibiotic resistance. -
Bacterial Inhibitor
PNU-105368 is an antibacterial compound that serves as a metabolite of linezolid. It demonstrates efficacy in inhibiting bacterial growth and is primarily excreted via the kidneys and feces. This compound is relevant for research focusing on bacterial resistance and the pharmacokinetics of oxazolidinones. -
Bacterial Inhibitor
Sisomicin is a broad-spectrum aminoglycoside antibiotic that targets bacterial ribosomes, inhibiting protein synthesis. It exhibits potent activity against Gram-positive bacteria, making it valuable in microbiological research. Sisomicin is commonly used in studies investigating bacterial resistance mechanisms and in the evaluation of antibacterial efficacy. -
Carbapenem Antibiotic
Meropenem-vaborbactam is a carbapenem antibiotic combined with a boronic acid-based beta-lactamase inhibitor, designed to effectively combat Enterobacteriaceae, particularly Klebsiella pneumoniae strains producing carbapenemases. This compound demonstrates notable in vitro activity against Pseudomonas aeruginosa, with MIC50 values of 0.5 μg/mL and MIC90 values of 8 μg/mL, making it a valuable tool for research in antimicrobial resistance and the development of new therapeutic strategies. -
Antibiotic
Virginiamycin Complex is a synergistic antibiotic comprised of two streptogramins, virginiamycin M (VM) and virginiamycin S (VS), derived from Streptomyces virginiae. This complex effectively irreversibly inhibits protein synthesis in bacteria, leveraging the persistent and catalytic action of VM to enhance the affinity of ribosomes for VS. Virginiamycin Complex exhibits significant antibacterial activity and is applied in research focused on studying bacterial resistance mechanisms and developing novel antimicrobial strategies. -
antibiotic
Etimicin sulfate is a fourth-generation aminoglycoside antibiotic that primarily targets bacterial protein synthesis by binding to the 30S ribosomal subunit. It exhibits potent antibacterial activity against a broad spectrum of Gram-negative and Gram-positive bacteria, making it valuable in treating various infections. Etimicin sulfate is particularly useful in clinical settings due to its high efficacy and low toxicity profile. -
Antibiotic for Poultry
Tylosin phosphate is a macrolide antibiotic that targets Gram-positive bacteria, exhibiting significant antimicrobial activity. It is commonly used as a feed additive in veterinary applications to promote growth in poultry, pigs, and cattle. Tylosin phosphate is effective in treating bacterial dysentery and respiratory diseases, making it an essential reagent in veterinary medicine and animal health research. -
Antibiotic
CRS3123 is a potent, orally active narrow-spectrum antibiotic that specifically targets bacterial methionyl-tRNA synthetase. It demonstrates significant efficacy against Clostridium difficile and aerobic Gram-positive bacteria while exhibiting minimal activity against Gram-negative bacteria, including anaerobes. CRS3123 is a valuable reagent for research focused on C. difficile infections and their treatment options. -
Antibiotic
Nemonoxacin is a potent, orally active broad-spectrum antibiotic that primarily targets bacterial infections. It demonstrates significant inhibitory effects against various species, including staphylococci, streptococci, enterococci, Neisseria gonorrhoeae, and Haemophilus influenza. This compound is valuable for research applications related to bacterial infections and the study of community-acquired pneumonia. -
Antibiotic
Cefodizime is a third-generation cephalosporin antibiotic that exhibits a broad spectrum of antibacterial activity. It is characterized by its low renal toxicity and favorable tolerance profile, along with immune modulation capabilities. This compound is particularly useful in the treatment of severe infections affecting the respiratory and urinary tracts.
